Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 10 June 2021
      19 Conversations | EFPIA's podcast series
 
 
Podcast: From raw materials to patients’ arms – how are COVID-19 vaccines made?
 
Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain:

"From raw materials to patients’ arms – how are COVID-19 vaccines made?".

Listen to hear their discussion on the challenge and how we're preparing for the future.

Read more →
 
 
      News
 
  08 June 2021 New ECIPE study on “International EU27 pharmaceutical production, trade, dependencies and vulnerabilities”...

Faced with the COVID-19 pandemic, global supply chains have shown remarkable resilience, and open markets and open trade...

Read more →
 
 
 
  04 June 2021 EFPIA response on the EU Communication on “Urgent Trade Policy Responses to the COVID-19 crisis"...

Compulsory licensing will not facilitate greater vaccine equity but could put the hard-won progress in fighting this...

Read more →
 
 
 
      Events
 
 
17 JUN 2021
  Lessons from the crisis: how a value-based approach can make health systems more... Virtual event

An event by the European Alliance for Value in Health

Learn more →
 
 
 
24 JUN 2021
  AMR: how can we prevent the next pandemic? Virtual event

An EFPIA virtual event

Learn more →
 
 
 
25 JUN 2021
  Beating cancer: Looking ahead, learning from the past Virtual event

The Impact of COVID-19 on Patient Access to Cancer Care in Europe

Learn more →
 
 
 
29 JUN 2021
  How can COVID-19 treatments help us on the road to recovery? Virtual event

An EFPIA virtual event

Learn more →
 
 
      What we are reading
« Future4care », the European healthcare startup accelerator launches in Paris 10 June 2021  (Future4Care) Read more →
EU proposes alternative to IP waiver to expand global vaccine access 08 June 2021  (Euractiv) Read more →
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline 07 June 2021  (STAT) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe